APGE
Apogee Therapeutics Inc
NASDAQ · Biotechnology
$62.24
+0.11 (+0.18%)
Performance
1D
—
1W
-5.17%
1M
-19.85%
3M
-1.13%
6M
+66.60%
1Y
+58.17%
YTD
-17.87%
Open$64.45
Previous Close$62.13
Day High$64.95
Day Low$61.75
52W High$84.56
52W Low$26.20
Volume1.37M
Avg Volume1.02M
Market Cap4.25B
P/E Ratio—
EPS$-4.36
SectorBiotechnology
Volume Analysis
1.34x average volume
Technical Indicators
SMA 50
$74.65
Below
SMA 200
$50.96
Above
RSI (14)
21.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+63.2% upside
Current
$62.24
$62.24
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 911.35M | 871.62M | 948.06M |
| Net Income | -243,438,723 | -174,175,180 | -203,637,440 |
| Profit Margin | -26.7% | -20.0% | -21.5% |
| EBITDA | -267,934,128 | -228,786,100 | -261,593,713 |
| Free Cash Flow | -101,879,133 | -97,401,406 | -128,866,616 |
| Rev Growth | +22.2% | +5.3% | +12.3% |
| Debt/Equity | 0.88 | 0.85 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |